CARDINAL HEALTH INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
AmerisourceBergen, Cardinal Health, McKesson, and Johnson & Johnson are nearing a $26B settlement for opioid lawsuits. New York reached a separate $1B deal with the distributors. Johnson & Johnson will contribute up to $5B nationally. Trials continue elsewhere.
Jim Cramer highlighted Cardinal Health (CAH) as a favorite, citing its specialty pharmaceuticals and healthcare services growth. Q4 revenue rose 6% to $63.7B but missed estimates, while adjusted EPS was $2.91. Fiscal 2027 guidance includes non-GAAP EPS of $12.40-$12.60 and adjusted free cash flow of $3.5B-$4B. Risks include execution, drug pricing, and customer concentration.
Cardinal Health's Chief Accounting Officer, Mary C. Scherer, sold 2,302 shares on August 19 at a weighted-average price of $237.39, according to an SEC filing. She now owns 2,811 shares, representing 0.001% of the company. Cardinal Health reported $254.2 billion in revenue and $1.7 billion in net income for the trailing 12 months. The company operates in healthcare services and products, serving hospitals, pharmacies, and clinical laboratories.
Over the past 7 days, alphai's AI scored 2 news stories mentioning CAH (CARDINAL HEALTH INC). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.
Recent CAH coverage spans financial news, corporate actions and earnings.
In the last 30 days, CAH insiders filed 31 SEC Form 4 transactions — no purchases and 31 sales ($59.6M). The most active reporter was Hollar Jason M., Chief Executive Officer, with 10 filings.
Settlement may affect cash flow and credit metrics.
Strong earnings beat on EPS and upbeat FY guidance could lift the stock, but valuation and customer concentration pose downside risks.
Minor dilution of insider ownership; unlikely to move price.
Minor dilution of insider ownership; unlikely to move price materially.
Significant insider sell may pressure the stock short-term.
alphai scores every news story that mentions CAH with an AI model for sentiment and relevance, and aggregates insider trades from CARDINAL HEALTH INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
AmerisourceBergen, Cardinal Health, McKesson, and Johnson & Johnson are nearing a $26B settlement for opioid lawsuits. New York reached a separate $1B deal with the distributors. Johnson & Johnson will contribute up to $5B nationally. Trials continue elsewhere.
3 min readJim Cramer highlighted Cardinal Health (CAH) as a favorite, citing its specialty pharmaceuticals and healthcare services growth. Q4 revenue rose 6% to $63.7B but missed estimates, while adjusted EPS was $2.91. Fiscal 2027 guidance includes non-GAAP EPS of $12.40-$12.60 and adjusted free cash flow of $3.5B-$4B. Risks include execution, drug pricing, and customer concentration.
3 min readCardinal Health's Chief Accounting Officer, Mary C. Scherer, sold 2,302 shares on August 19 at a weighted-average price of $237.39, according to an SEC filing. She now owns 2,811 shares, representing 0.001% of the company. Cardinal Health reported $254.2 billion in revenue and $1.7 billion in net income for the trailing 12 months. The company operates in healthcare services and products, serving hospitals, pharmacies, and clinical laboratories.
1 min readCardinal Health CFO Aaron Alt sold 42,000 shares for $9.9M on August 18, reducing his holdings to 20,495 shares. The sale price was $236.34, slightly above the $234.98 closing price. Cardinal Health is a global healthcare services and products provider with $254.2B TTM revenue.
1 min readStephen M. Mason, CEO of Cardinal Health's GMPD Segment, sold 35,000 shares (55% of his position) for $8.27 million on August 18, leaving 18,061 shares worth $4.24 million. Cardinal Health (CAH) has a $55.0B market cap, $254.2B TTM revenue, and $1.7B TTM net income. The stock was up 57% over the past year.
1 min readCardinal Health's (CAH) PSS Segment CEO Deborah Weitzman sold 7,354 shares at a weighted average price of $235.45, reducing her stake by 9%. She still holds 77,901 shares worth $18.31 million. Cardinal Health has a market cap of $55.0 billion and TTM revenue of $254.2 billion.
2 min readCardinal Health, Inc. (CAH) CIO Michelle D. Greene sold 11,650 shares on August 18, according to an SEC filing. The shares were sold at prices ranging from $234.07 to $237.32, with a weighted average of $235.72. Post-sale, Greene retains 10,330 shares. Cardinal Health has a market cap of $55.0 billion and generated $254.2 billion in TTM revenue, with net income of $1.7 billion.
1 min readCardinal Health's (CAH) Chief Legal Officer, Jessica L. Mayer, sold 29,436 shares at $236.19 each on August 18, totaling ~$7.0 million. Post-transaction, she holds 33,076 shares. The company has a $55.0 billion market cap and $254.2 billion TTM revenue. CFO and CIO also sold shares the same day. Management discussed 340B and IRA pricing pressures during the earnings call.
1 min readCardinal Health's CEO sold 124,529 shares in two days, totaling $29.4 million, following the vesting of restricted stock. The company reported fiscal 2026 revenue of $254 billion, up 14%, and $5 billion in adjusted free cash flow. Non-GAAP earnings per share have more than doubled since fiscal 2022. However, the medical products and distribution segment faces challenges due to tariff relief and rising costs.
1 min readScherer Mary C. (Chief Accounting Officer) sold 2,302 shares of CARDINAL HEALTH INC (CAH) at an average of $237.39 ($237.39–$237.40, $0.55M total) across 2 trades on 2026-08-19.
1 min read
